Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure
{{output}}
Background: A vero cell-based inactivated Rabies Vaccine (Rabivax-S) and Rabies Human Monoclonal Antibody (Rabishield) have been approved since 2016. A post-marketing surveillance was conducted in India from 2020 to 2021 to gathe... ...
